Verrica Pharmaceuticals Inc. (VRCA) stock
VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.14−0.06 (-1.88%)
Close on Nov 17, 2026Market cap $53.94MP/E –Yield –
Verrica Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Verrica Pharmaceuticals's price to sales ratio was 2.2× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 1.9× to 201.9×, with a median of 14.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.2× | −0.3 |
| 2025 | Dec 31, 2025 | 2.6× | −0.9 |
| 2024 | Dec 31, 2024 | 3.5× | −92.6 |
| 2023 | Dec 29, 2023 | 96.1× | +83.5 |
| 2022 | Dec 30, 2022 | 12.6× | – |
See a number that looks wrong?